CL2007001178A1 - Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores. - Google Patents
Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores.Info
- Publication number
- CL2007001178A1 CL2007001178A1 CL2007001178A CL2007001178A CL2007001178A1 CL 2007001178 A1 CL2007001178 A1 CL 2007001178A1 CL 2007001178 A CL2007001178 A CL 2007001178A CL 2007001178 A CL2007001178 A CL 2007001178A CL 2007001178 A1 CL2007001178 A1 CL 2007001178A1
- Authority
- CL
- Chile
- Prior art keywords
- anxiety
- tetrahydro
- pyrimidine
- mglur5
- medications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos derivados de tetrahidro[1,2,4]triazolo[4,3-a]pirimidina; composición farmacéutica; y uso para el tratamiento o prevención de reflujo gastroesofágico, ansiedad y síndrome de intestino irritable entre otros.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79766306P | 2006-05-05 | 2006-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007001178A1 true CL2007001178A1 (es) | 2008-01-18 |
Family
ID=38668441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2007001178A CL2007001178A1 (es) | 2006-05-05 | 2007-04-25 | Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores. |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070259860A1 (es) |
EP (1) | EP2027129A2 (es) |
JP (1) | JP2009536213A (es) |
KR (1) | KR20090018935A (es) |
CN (1) | CN101484455A (es) |
AR (1) | AR060811A1 (es) |
AU (1) | AU2007248292A1 (es) |
BR (1) | BRPI0710980A2 (es) |
CA (1) | CA2650255A1 (es) |
CL (1) | CL2007001178A1 (es) |
EC (1) | ECSP088884A (es) |
IL (1) | IL194815A0 (es) |
MX (1) | MX2008013834A (es) |
NO (1) | NO20084852L (es) |
RU (1) | RU2008141511A (es) |
TW (1) | TW200808800A (es) |
UY (1) | UY30308A1 (es) |
WO (1) | WO2007130824A2 (es) |
ZA (1) | ZA200809019B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200821305A (en) * | 2006-10-05 | 2008-05-16 | Astrazeneca Ab | MGluR5 modulators |
WO2009054787A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
KR20100089091A (ko) * | 2007-10-26 | 2010-08-11 | 아스트라제네카 아베 | Mglur5의 조절제로서의 아미노 1,2,4-트리아졸 유도체 |
WO2009054790A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Amide linked heteroaromatic derivatives as modulators of mglur5 |
WO2009054786A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
WO2009054791A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
WO2009054793A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
WO2009054785A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole ether derivatives as modulators of mglur5 |
CA2747507A1 (en) * | 2008-12-18 | 2010-06-24 | Astrazeneca Ab | New process for the preparation of 1- [5-(3-chloro-phenyl)-isooxazol-3-yl]-ethanone and (r)-1-[5-(3-chloro-phenyl)-isooxazol-3-yl]-ethanol |
JP5620129B2 (ja) * | 2009-03-19 | 2014-11-05 | 富士フイルム株式会社 | 光学フィルム、位相差板、楕円偏光板、液晶表示装置、及び化合物 |
US20120142672A1 (en) | 2009-07-13 | 2012-06-07 | Tatsuki Koike | Heterocyclic compound and use thereof |
JP5775094B2 (ja) * | 2009-12-29 | 2015-09-09 | イーライ リリー アンド カンパニー | 統合失調症の処置に有用な選択的mGlu5受容体増強因子としてのテトラヒドロトリアゾロピリジン化合物 |
CA2809779A1 (en) | 2010-09-02 | 2012-03-08 | Takeda Pharmaceutical Company Limited | Fused triazoles for the treatment or prophylaxis of mild cognitive impairment |
AR094553A1 (es) | 2013-01-23 | 2015-08-12 | Astrazeneca Ab | Formas de oxadiazolpirazina |
EP2857387A1 (en) | 2013-10-07 | 2015-04-08 | Boehringer Ingelheim International Gmbh | Process for manufacturing 1,6-dihydro-6-oxo-4-pyridazine carboxylic acid |
TW202208347A (zh) | 2020-05-06 | 2022-03-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基三唑化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3896900A (en) * | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Treatment of pain |
EP1536790A2 (en) * | 2002-08-09 | 2005-06-08 | AstraZeneca AB | Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
WO2004014902A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
CA2556263A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
MY152888A (en) * | 2004-02-18 | 2014-11-28 | Astrazeneca Ab | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists. |
US7585881B2 (en) * | 2004-02-18 | 2009-09-08 | Astrazeneca Ab | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
-
2007
- 2007-04-24 TW TW096114393A patent/TW200808800A/zh unknown
- 2007-04-25 EP EP07811855A patent/EP2027129A2/en not_active Withdrawn
- 2007-04-25 UY UY30308A patent/UY30308A1/es not_active Application Discontinuation
- 2007-04-25 RU RU2008141511/04A patent/RU2008141511A/ru not_active Application Discontinuation
- 2007-04-25 CN CNA2007800254542A patent/CN101484455A/zh active Pending
- 2007-04-25 CL CL2007001178A patent/CL2007001178A1/es unknown
- 2007-04-25 AU AU2007248292A patent/AU2007248292A1/en not_active Abandoned
- 2007-04-25 AR ARP070101784A patent/AR060811A1/es unknown
- 2007-04-25 WO PCT/US2007/067371 patent/WO2007130824A2/en active Application Filing
- 2007-04-25 JP JP2009509957A patent/JP2009536213A/ja active Pending
- 2007-04-25 MX MX2008013834A patent/MX2008013834A/es not_active Application Discontinuation
- 2007-04-25 US US11/790,429 patent/US20070259860A1/en not_active Abandoned
- 2007-04-25 BR BRPI0710980-6A patent/BRPI0710980A2/pt not_active IP Right Cessation
- 2007-04-25 KR KR1020087029721A patent/KR20090018935A/ko not_active Application Discontinuation
- 2007-04-25 CA CA002650255A patent/CA2650255A1/en not_active Abandoned
-
2008
- 2008-10-21 ZA ZA200809019A patent/ZA200809019B/xx unknown
- 2008-10-22 IL IL194815A patent/IL194815A0/en unknown
- 2008-11-12 EC EC2008008884A patent/ECSP088884A/es unknown
- 2008-11-18 NO NO20084852A patent/NO20084852L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007130824A2 (en) | 2007-11-15 |
EP2027129A2 (en) | 2009-02-25 |
ZA200809019B (en) | 2009-08-26 |
ECSP088884A (es) | 2008-12-30 |
JP2009536213A (ja) | 2009-10-08 |
NO20084852L (no) | 2009-01-14 |
RU2008141511A (ru) | 2010-06-20 |
BRPI0710980A2 (pt) | 2011-05-31 |
CA2650255A1 (en) | 2007-11-15 |
UY30308A1 (es) | 2007-11-30 |
KR20090018935A (ko) | 2009-02-24 |
US20070259860A1 (en) | 2007-11-08 |
IL194815A0 (en) | 2009-08-03 |
AU2007248292A1 (en) | 2007-11-15 |
CN101484455A (zh) | 2009-07-15 |
AU2007248292A8 (en) | 2008-12-04 |
MX2008013834A (es) | 2008-11-10 |
AR060811A1 (es) | 2008-07-16 |
WO2007130824A3 (en) | 2008-05-22 |
TW200808800A (en) | 2008-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007001178A1 (es) | Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores. | |
SV2005002148A (es) | "compuestos moduladores de la actividad c-kit y usos de los mismos" | |
BRPI0510170B8 (pt) | composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto | |
TW200738238A (en) | Combination of a long-acting hypnotic agent and a short-acting hypnotic agent, pharmaceutical composition containing it and its application in therapeutics | |
CL2007002649A1 (es) | Composicion farmaceutica que comprende 2-[6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo; y uso para el tratamiento de la diabetes. | |
CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
ECSP055783A (es) | Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes | |
EA201300246A1 (ru) | Ингибиторы тирозинкиназы брутона | |
UY30942A1 (es) | Nuevos derivados de 3-([1,2,4,]triazolo[4,3-a]piridin-7-il)benzamida | |
CY1112281T1 (el) | Αναστολεις διπεπτιδυλ πεπτιδασης για τη θεραπεια του διαβητη | |
ECSP088906A (es) | PIRAZOLO 1,5-a PIRIMIDINAS | |
CL2008001946A1 (es) | Compuestos derivados de imidazol, antagonistas de receptores ccr2, ccr3, ccr5; procedimiento de preparacion; y uso en el tratamiento de enfermedades vasculares perifericas. | |
CL2011001215A1 (es) | Compuestos derivados de pirimidina, inhibidores de tirosina quinasa; composiciones farmaceuticas que los comprenden; y su uso en el tratamiento y/o prevencion de cancer, enfermedades inflamatorias y enfermedades autoinmunes. | |
CL2007002867A1 (es) | Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras. | |
TW200716631A (en) | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof | |
CL2007002492A1 (es) | Compuestos derivados de bi-,tri o policiclos no aromaticos, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; proceso de preparacion de estos; composicion famaceutica que los comprende; uso en el tratamiento de enfermedades tales como la obesidad, diabetes y dislipidemia, entre otras. | |
NO20081628L (no) | Benzodiazepiner som HCV-inhibitorer | |
CL2004000449A1 (es) | Compuestos derivados de imidazol-4-il-etinil-piridina, para tratar trastornos mediados por el receptor mglur5; procedimiento de preparacion de los compuestos; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
MA31305B1 (fr) | Administration hebdomadaire d'inhibiteurs de la dipeptidyle peptidase | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
CL2007001175A1 (es) | Compuestos derivados de triazol-pirrolidina sustituidos, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y uso de los compuestos en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores. | |
CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. |